---
title: "Ocean Biomedical, Inc. (OCEA.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/OCEA.US.md"
symbol: "OCEA.US"
name: "Ocean Biomedical, Inc."
industry: "Biotechnology"
---

# Ocean Biomedical, Inc. (OCEA.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.oceanbiomedical.com](https://www.oceanbiomedical.com) |

## Company Profile

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company’s oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.01 | 70/605 | - | - | - |
| PB | 0.00 | 451/605 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/OCEA.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/OCEA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/OCEA.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
